Scribd
Upload
230 views3 pages

Tinea Versicolor Treatment & Management - Medical Care, Diet

Tinea versicolor is a non-contagious fungal skin condition that can be treated effectively with various topical and oral antifungal agents, though recurrence is common. Topical treatments include selenium sulfide and azole antifungals, while oral options include fluconazole and itraconazole, with specific dosing regimens recommended. Dietary changes have not been shown to be effective in managing the condition.

Uploaded by

Miranda Yudhi Cyubidubiduu
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
230 views3 pages

Tinea Versicolor Treatment & Management - Medical Care, Diet

Tinea versicolor is a non-contagious fungal skin condition that can be treated effectively with various topical and oral antifungal agents, though recurrence is common. Topical treatments include selenium sulfide and azole antifungals, while oral options include fluconazole and itraconazole, with specific dosing regimens recommended. Dietary changes have not been shown to be effective in managing the condition.

Uploaded by

Miranda Yudhi Cyubidubiduu
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

1/3/2016

TineaVersicolorTreatment&Management:MedicalCare,Diet

TineaVersicolorTreatment&Management
Author:CraigGBurkhart,MD,MPHChiefEditor:DirkMElston,MDmore...
Updated:Nov19,2015

MedicalCare
Patientsshouldbeinformedthattineaversicoloriscausedbyafungusthatisnormallypresentontheskinsurface
[Link]
changes,[Link]
common,andprophylactictherapymayhelpreducethehighrateofrecurrence.
Tineaversicolorcanbesuccessfullytreatedwithvariousagents. [16]Effectivetopicalagentsincludeselenium
sulfide,sodiumsulfacetamide,ciclopiroxolamine, [17]aswellasazoleandallylamineantifungals. [18,19,20,21,22]
Variousregimenscanbeused.Seleniumsulfidelotionisliberallyappliedtoaffectedareasoftheskindailyfor2
[Link]
resistantcases,overnightapplicationcanbehelpful.Topicalazoleantifungalscanbeappliedeverynightfor2
[Link]
patientswithwidespreaddisease,[Link]
[Link]
treatmentoftineaversicolor,thetopicalfoammaybeusefulinsomepatients. [23]
Oraltherapyisalsoeffectivefortineaversicolorandisoftenpreferredbypatientsbecauseitismoreconvenientand
[Link],[Link],and
itraconazolearethepreferredoralagents. [24,25,26][Link],a
10day200mgdailytherapyandasasingledose400mgtreatmentarepopular,bothwithcomparableresults. [27]
[Link]
200mg/[Link].
[28,29]Areviewsuggestedthefollowingdosingregimens:200mg/dfor5or7daysofitraconazole,300mg/wkfor2
weeksoffluconazole,and200mg/dfor2daysofpramiconazole. [30]
Oraltherapydoesnotpreventthehighrateofrecurrence,andtreatmentwithanoralortopicalagentmayneedto
[Link]
withoutrisk,thedecisiontotreatwithanoralagentshouldbemadeonlyafteracompletediscussionoftherisks
involved. [31]Inthecaseoforalterbinafine,somesubgroupsofMfurfurapparentlyarenotclinicallyresponsive,
althoughinvitrostudiessuggestfungistaticactivity. [32]Also,aregimenof1tabletamonthoffluconazoleor
itraconazolehasbeenusedsuccessfullytoprophylacticallypreventrecurrences. [33]
Reportsdescribesuccessfultreatmentoftineaversicolorwithphotodynamictherapy. [34,35]

Diet
Dietaryalterationshavenotprovedsuccessfulinthetreatmentoftineaversicolor.
Medication

ContributorInformationandDisclosures
Author
CraigGBurkhart,MD,MPHClinicalProfessor,DepartmentofMedicine,MedicalCollegeofOhioClinical
AssistantProfessor,DepartmentofMedicine,OhioUniversityCollegeofOsteopathicMedicine
CraigGBurkhart,MD,MPHisamemberofthefollowingmedicalsocieties:AssociationofMilitary
Dermatologists,AmericanCollegeofAestheticandCosmeticPhysiciansAmericanSocietyof
Aesthetic/CosmeticPhysicians,MichiganDermatologicalSociety,AcademyofMedicineofToledoandLucas
County,OhioDermatologicalAssociation,AmericanAcademyofDermatology,OhioStateMedicalAssociation,
PhiBetaKappa
Disclosure:Nothingtodisclose.
Coauthor(s)
CraigNBurkhart,MDMSBS,AssistantProfessor,DepartmentofDermatology,UniversityofNorthCarolinaat
ChapelHillSchoolofMedicine
CraigNBurkhart,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofDermatology,
AmericanCollegeofPhysicians,AmericanMedicalAssociation
Disclosure:Nothingtodisclose.
SpecialtyEditorBoard
MichaelJWells,MD,FAADAssociateProfessor,DepartmentofDermatology,TexasTechUniversityHealth
SciencesCenter,PaulLFosterSchoolofMedicine
MichaelJWells,MD,FAADisamemberofthefollowingmedicalsocieties:AlphaOmegaAlpha,American
AcademyofDermatology,AmericanMedicalAssociation,TexasMedicalAssociation
Disclosure:Nothingtodisclose.

[Link]

1/3

1/3/2016

TineaVersicolorTreatment&Management:MedicalCare,Diet

EdwardFChan,MDClinicalAssistantProfessor,DepartmentofDermatology,UniversityofPennsylvania
SchoolofMedicine
EdwardFChan,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofDermatology,
AmericanSocietyofDermatopathology,SocietyforInvestigativeDermatology
Disclosure:Nothingtodisclose.
ChiefEditor
DirkMElston,MDProfessorandChairman,DepartmentofDermatologyandDermatologicSurgery,Medical
UniversityofSouthCarolinaCollegeofMedicine
DirkMElston,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofDermatology
Disclosure:Nothingtodisclose.
AdditionalContributors
KathrynSchwarzenberger,MDAssociateProfessorofMedicine,DivisionofDermatology,Universityof
VermontCollegeofMedicineConsultingStaff,DivisionofDermatology,FletcherAllenHealthCare
KathrynSchwarzenberger,MDisamemberofthefollowingmedicalsocieties:Women'sDermatologicSociety,
AmericanContactDermatitisSociety,MedicalDermatologySociety,DermatologyFoundation,AlphaOmega
Alpha,AmericanAcademyofDermatology
Disclosure:Nothingtodisclose.
Acknowledgements
LorieGottwald,MDChief,DivisionofDermatology,AssociateProfessor,DepartmentofInternalMedicine,
MedicalCollegeofOhioatToledo
LorieGottwald,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofDermatology,
AmericanCollegeofPhysicians,AmericanMedicalAssociation,AmericanMedicalStudent
Association/Foundation,andAmericanMedicalWomen'sAssociation
Disclosure:Nothingtodisclose.

References
1. CrespoErchigaV,[Link].2006
Apr.19(2):13947.[Medline].
2. GaitanisG,VelegrakiA,AlexopoulosEC,ChasapiV,TsigoniaA,[Link]
[Link]
[Link].2006May.154(5):8549.[Medline].
3. MorishitaN,SeiY,[Link]
[Link].2006Feb.161(2):615.[Medline].
4. RinconS,CelisA,SopoL,MottaA,[Link]
[Link].2005Jun.25(2):18995.[Medline].
5. KrisantyRI,BramonoK,[Link]
[Link].2009May.52(3):25762.[Medline].
6. BlaesAH,CavertWP,[Link]:isitapulmonarypathogeninthestemcelltransplant
population?.[Link],2009.11:313317.[Medline].
7. MuhammadN,KamalM,IslamT,IslamN,[Link]
[Link].2009Jan.18(1):315.
[Medline].
8. HeSM,DuWD,YangS,[Link].2008Jan.
51(1):5562.[Medline].
9. SuwatteeP,ChamPM,SolomonRK,[Link].
2009Feb.36(2):2856.[Medline].
10. BurkhartCG,DvorakN,[Link].
Cutis.1981.27(1):568.[Medline].
11. GulecAT,DemirbilekM,SeckinD,etal.Superficialfungalinfectionsin102renaltransplantrecipients:a
[Link].2003Aug.49(2):18792.[Medline].
12. [Link].2010.
28:185188.[Medline].
13. KilicM,OguztuzumS,KaradagS,CakirE,AydinM,OzturkL.ExpressionofGSTM4andGSTT1in
patientswithTineaversicolor,Tineainguinalis,andTineapedisinfections:[Link]
Dermatology.2011.36:590594.[Medline].
14. LimSL,[Link].2008
Aug.144(8):10589.[Medline].
15. JanakiC,SentamilselviG,JanakiVR,[Link]
[Link].1997.139(2):714.[Medline].
16. GuptaAK,[Link]:[Link]
Pharmacother.2014Aug.15(12):170713.[Medline].

[Link]

2/3

1/3/2016

TineaVersicolorTreatment&Management:MedicalCare,Diet

17. GuptaAK,[Link]:[Link]
Dermatol.2003Sep.42Suppl1:39.[Medline].
18. HullCA,JohnsonSM.Adoubleblindcomparativestudyofsodiumsulfacetamidelotion10%versus
seleniumsulfidelotion2.5%inthetreatmentofpityriasis(tinea)[Link].2004Jun.73(6):4259.
[Medline].
19. VermeerBJ,StaatsCC.Theefficacyofatopicalapplicationofterbinafine1%solutioninsubjectswith
pityriasisversicolor:[Link].1997.194Suppl1:224.[Medline].
20. CarrilloMunozAJ,GiusianoG,EzkurraPA,[Link]:updatedreviewofatopical
[Link].2005Jun.3(3):33342.[Medline].
21. GoldM,BridgesT,AvakianE,PlaumS,PappertEJ,FleischerAB,[Link]
hydrochloride1%[Link].Sept2011.9:2836.[Medline].
22. CroxtallJ,[Link]:areviwofitsuseinthemanagementofsuperficialmycosesin
[Link]/AdisInternational.Jan2009.69:339359.[Medline].
23. CantrellWC,ElewksiBE.Canpityriasisversicolorbetreatedwith2%ketoconazolefoam?.JDrugs
Dermatol.2014Jul1.13(7):8559.[Medline].
24. [Link],randomized,placebocontrolledevaluationofshorttermtreatmentwithoral
[Link].1996May.34(5Pt1):7857.[Medline].
25. KarakasM,DurduM,[Link].
2005Jan.32(1):1921.[Medline].
26. PartapR,KaurI,ChakrabartiA,[Link]
[Link].2004.208(1):559.[Medline].
27. FernandezNavaHD,LayaCuadraB,TiancoEA.Comparisonofsingledose400mgversus10day200
[Link].1997Jan.36(1):646.
[Medline].
28. WahabMA,AliME,RahmanMH,ChowdhurySA,MonamieNS,SultanaN,[Link](400mg)
versus7day(200mg)dailydoseitraconazoleinthetreatmentoftineaversicolor:arandomizedclinicaltrial.
MymensinghMedJ.2010Jan.19(1):726.[Medline].
29. FaergemannJ,ToddG,PatherS,[Link],randomized,placebocontrolled,dosefinding
[Link].2009Dec.
61(6):9716.[Medline].
30. GuptaAK,LaneD,[Link]
[Link].2014MarApr.18(2):7990.[Medline].
31. MellenLA,ValleeJ,FeldmanSR,[Link].
JDermatologTreat.2004Jun.15(3):18992.[Medline].
32. LeemingJP,SansomJE,[Link]
Dermatol.1997Nov.137(5):7647.[Medline].
33. FaergemannJ,GuptaAK,AlMofadiA,AbanamiA,ShareaahAA,[Link]
intheprophylactictreatmentofpityriasis(tinea)[Link].2002Jan.138(1):6973.
[Medline].
34. KimYJ,KimYC.Successfultreatmentofpityriasisversicolorwith5aminolevulinicacidphotodynamic
[Link].2007Sep.143(9):121820.[Medline].
35. QiaoJ,LiR,DingY,[Link]:anevidence
[Link].2010.170:339343.[Medline].
36. [Link].1983.6:812.
MedscapeReference2011WebMD,LLC

[Link]

3/3

You might also like